Non-Hodgkin Lymphoma Clinical Trials in Aurora, Colorado
8 studies are recruiting for non-hodgkin lymphoma in Aurora, Colorado right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
This study is a Phase 1 multicenter study with a Dose Escalation and Dose Expansion evaluating safety and efficacy of MT-601 administration to patients with Relapsed or Refractory Lymphoma. The starting dose administered is 200 x 10\^6 cells (flat dosing).
- Stage
- Phase 1
- Ages
- 18 to 100
- Site
- University of Colorado, Aurora, Colorado
- Locations
- 7 in total
- Run by
- Marker Therapeutics, Inc.
-
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
This Phase 3 study compares rondecabtagene autoleucel (ronde-cel), a dual-targeting CD19/CD20 CAR T-cell therapy, with investigator's choice of CD19 CAR T-cell therapy in patients with relapsed or refractory large B-cell lymphoma in the second-line setting.
- Stage
- Phase 3
- Ages
- 18 and older
- Site
- University of Colorado, Aurora, Colorado
- Locations
- 36 in total
- Run by
- Lyell Immunopharma, Inc.
-
Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients
This open-label, single arm phase 1 trial aims to determine the safety and tolerability of anti-CD19 and anti-CD22 chimeric antigen receptor-expressing (CAR) T cells (CD19x22 CAR T) in adolescents and adults with relapsed/refractory (R/R) B-cell Non-Hodgkin Lymphoma (B-NHL). This trial will determi…
- Stage
- Phase 1
- Ages
- 16 and older
- Site
- University of Colorado Hospital, Aurora, Colorado
- Run by
- University of Colorado, Denver
-
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.
- Stage
- Not phased
- Ages
- Any age
- Site
- Children's Hospital Colorado, Aurora, Colorado
- Locations
- 142 in total
- Run by
- Center for International Blood and Marrow Transplant Research
-
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
The use of venetoclax-based therapies for pediatric patients with relapsed or refractory malignancies is increasingly common outside of the clinical trial setting. For patients who cannot swallow tablets, it is common to crush the tablets and dissolve them in liquid to create a solution. However, n…
- Stage
- Not phased
- Ages
- 0 to 38
- Site
- Children's Hospital Colorado, Aurora, Colorado
- Locations
- 5 in total
- Run by
- Children's Hospital Medical Center, Cincinnati
-
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
This is a multi-site clinical study enrolling 2000 newly diagnosed patients with breast, colorectal, melanoma, non-Hodgkin lymphoma, or non-small cell lung cancer, who are planning to receive one or more systemic cancer directed therapies with chemotherapy and/or (immune checkpoint inhibitors) ICIs.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Rocky Mountain Cancer Centers-Aurora, Aurora, Colorado
- Locations
- 467 in total
- Run by
- Wake Forest University Health Sciences
-
Improving Communication and Building a Stronger Medical Home Among Spanish-speaking Families
This study will seek to improve communication with Spanish speaking families and patients with Cancer and Blood Disorders.
- Stage
- Not phased
- Ages
- Up to 22
- Site
- Children's Hospital Colorado, Aurora, Colorado
- Run by
- University of Colorado, Denver
-
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinical impact on pts with advanced cancer to facilitate clinical…
- Stage
- Not phased
- Ages
- Any age
- Site
- Massive Bio SYNERGY-AI site, Aurora, Colorado
- Locations
- 68 in total
- Run by
- Massive Bio, Inc.
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.